Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Yi Wen Xiao"'
Autor:
Xuan Peng, Ya Wang, Li Juan Tang, Xi Xi Li, Yi Wen Xiao, Zhi Bin Zhang, Ri Ming Yan, Hui Lin Yang, Jun Chang, Bo Zhu, Du Zhu
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 32, Iss 6, Pp 1496-1506 (2018)
Plant growth promoters produced by microorganisms can play a significant role in the induction of some important physiological responses in the growth and development of plants. In this study, we provided a first insight into revealing the diversity
Externí odkaz:
https://doaj.org/article/8398e46b3b5b4f36bb8f99e1ab7c131c
Publikováno v:
Travel Medicine and Infectious Disease, Vol 60, Iss , Pp 102743- (2024)
Externí odkaz:
https://doaj.org/article/c233f2f94eaa460ea564c7cab5eccaf5
Autor:
Hai-Hui Zhuang, Ying Chen, Qin Hu, Wen-Ming Long, Xiao-Li Wu, Qin Wang, Tian-Tian Xu, Qiang Qu, Yi-Ping Liu, Yi-Wen Xiao, Jian Qu
Publikováno v:
Journal of Infection and Public Health, Vol 16, Iss 6, Pp 938-947 (2023)
Objectives: Limited data on clinical and microbiological efficacy, patient mortality, and other associated factors are available for ceftazidime/avibactam (CAZ/AVI)-based regimens for carbapenem-resistant Gram-negative bacteria (CR-GNB). This study a
Externí odkaz:
https://doaj.org/article/74ba3a9cf19e4d7c86377fad7c9a878d
Autor:
A-Xi Shi, Qiang Qu, Hai-Hui Zhuang, Xin-Qi Teng, Wei-Xin Xu, Yi-Ping Liu, Yi-Wen Xiao, Jian Qu
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Objectives: Augmented renal clearance (ARC) is a state of enhanced renal function commonly observed in 30%–65% of critically ill patients despite normal serum creatinine levels. Using unadjusted standard dosing regimens of renally eliminated drugs
Externí odkaz:
https://doaj.org/article/bacc6267e4814c2896993920dfc02cbe
Autor:
Yi‐Chang Zhao, Xiao‐Bin Lin, Bi‐Kui Zhang, Yi‐wen Xiao, Ping Xu, Feng Wang, Da‐Xiong Xiang, Xu‐Biao Xie, Feng‐Hua Peng, Miao Yan
Publikováno v:
Clinical and Translational Science, Vol 14, Iss 2, Pp 702-711 (2021)
Voriconazole is the mainstay for the treatment of invasive fungal infections in patients who underwent a kidney transplant. Variant CYP2C19 alleles, hepatic function, and concomitant medications are directly involved in the metabolism of voriconazole
Externí odkaz:
https://doaj.org/article/a7d067fcc5ae48b3b82b61514aa16f8a
Publikováno v:
Molecules, Vol 26, Iss 7, p 1828 (2021)
Three new helvolic acid derivatives (named sarocladilactone A (1), sarocladilactone B (2) and sarocladic acid A (3a)), together with five known compounds (6,16-diacetoxy-25-hy- droxy-3,7-dioxy-29-nordammara-1,17(20)-dien-21-oic acid (3b), helvolic ac
Externí odkaz:
https://doaj.org/article/876fb6306bbe4f10a5143ec96e383cdc
Autor:
Xubiao Xie, Ping Xu, Bikui Zhang, Feng Wang, Fenghua Peng, Xiao-bin Lin, Da-Xiong Xiang, Yi-Wen Xiao, Miao Yan, Yi-Chang Zhao
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 14, Iss 2, Pp 702-711 (2021)
Clinical and Translational Science, Vol 14, Iss 2, Pp 702-711 (2021)
Voriconazole is the mainstay for the treatment of invasive fungal infections in patients who underwent a kidney transplant. Variant CYP2C19 alleles, hepatic function, and concomitant medications are directly involved in the metabolism of voriconazole
Autor:
Bikui Zhang, Xi‐jing Chen, Feng Wang, Yi Tian, Guozhong Gong, Min Zhang, Yongfang Jiang, Jianjun Zou, Yi-Wen Xiao, Miao Yan, Da-Xiong Xiang, Yi-Chang Zhao, Wenlong Wang, Wu Liang, Bai‐li Song, Dan Tang
Publikováno v:
British Journal of Clinical Pharmacology. 87:1890-1902
AIMS Voriconazole is a broad-spectrum antifungal agent for the treatment of invasive fungal infections. There is limited information about the pharmacokinetics and appropriate dosage of voriconazole in patients with liver dysfunction. This study aime
Publikováno v:
International Journal of General Medicine, Vol 2009, Iss default, Pp 1-4 (2008)
Ke-Qing Qian1, Heng Ye1, Yi-Wen Xiao1, Yong-Yi Bao2, Chun-Jian Qi11Department of Oncology; 2Department of Pathology, the Changzhou No. 2 People’s Hospital Affiliated to Nanjing Medical University, Changzhou, ChinaAbstract: Tumor lysis syndrome (TLS
Externí odkaz:
https://doaj.org/article/2ce72a4bbb7b4ee79df9aecf6bad500c
Autor:
Feng Wang, Min Zhang, Yongfang Jiang, Bikui Zhang, Jiakai Li, Guozhong Gong, Da-Xiong Xiang, Yi-Wen Xiao, Miao Yan, Yi-Chang Zhao, Jingjing Hou
Publikováno v:
Antibiotics, Vol 10, Iss 1130, p 1130 (2021)
Antibiotics
Volume 10
Issue 9
Antibiotics
Volume 10
Issue 9
This prospective observational study aimed to clinically describe voriconazole administrations and trough concentrations in patients with Child–Pugh class C and to investigate the variability of trough concentration. A total of 144 voriconazole tro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d16f153d716059d45425e5220d77d5b